Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 14;60(5):2246-2255.
doi: 10.1093/rheumatology/keaa569.

Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease

Affiliations

Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease

Debashish Danda et al. Rheumatology (Oxford). .

Abstract

Objectives: To describe the clinical profile of Asian Indian patients with Takayasu's arteritis (TAK) and to compare clinical features and outcome of childhood-onset Takayasu's arteritis (cTAK) with adult-onset TAK (aTAK).

Methods: Data related to clinical features and response to treatment of patients with cTAK (age of onset <16 years) and aTAK from a large observational cohort in our tertiary care teaching hospital were noted and compared.

Results: Altogether, 602 patients (cTAK = 119; aTAK = 483) were studied. Patients with cTAK had a blunted female: male ratio; but fever, elevated acute phase reactants, involvement of abdominal aorta or its branches, hypertension, abdominal pain, elevated serum creatinine and cardiomyopathy were more common in cTAK as compared with aTAK. Patients with aTAK were more likely to have aortic-arch disease and claudication than cTAK. During follow-up, complete remission was more common in cTAK (87% vs 66%; P < 0.01), but subsequent relapses were equally common (30% vs 27%; P = 0.63). Independent associations of disease duration at presentation with disease extent [Disease Extent Index in TAK (DEI.Tak)] and damage [TAK Damage Score (TADS)] were observed (P ≤ 0.01). Moreover, 54% of patients with symptom duration of >5 years at presentation still continued to have elevated CRP suggesting continued and active inflammation warranting escalation or inititation of immunosuppression.

Conclusion: Patients with cTAK are more likely to have arterial disease below the diaphragm, systemic inflammation and achieve remission. Disease of the aortic arch is more common in patients with aTAK. Longer duration of symptoms prior to initiation of immunosuppression, thereby leading to extensive disease and damage, reflects ongoing disease activity as the rule rather than exception in untreated TAK.

Keywords: India; Takayasu’s arteritis; autoimmune; childhood Takayasu’s arteritis; childhood vasculitis; large-vessel vasculitis; vasculitis.

PubMed Disclaimer

Figures

<sc>Fig</sc>. 1
Fig. 1
Flow chart of patients included in this study
<sc>Fig</sc>. 2
Fig. 2
Baseline clinical characteristics of all patients with Takayasu’s arteritis
<sc>Fig</sc>. 3
Fig. 3
Distribution of arterial lesions assessed by angiography in 585 patients with Takayasu's arteritis ABD AO, abdominal aorta; ARCH, aortic arch; ASAO, ascending aorta; CA, coeliac artery; DTA, descending thoracic aorta; IMA, inferior mesenteric artery; INNOM, innominate artery; LAX, left axial artery; LBR, left brachial artery; LCCA, left common carotid artery; LCIA, left common iliac artery; LECA, left internal carotid artery; LEXI, left external iliac artery; LFA, left femoral artery; LICA, left internal carotid artery; LRA, left renal artery; LSCA, left subclavian artery; LVA, left vertebral artery; RAX, right axillary artery; RBR, right brachial artery; RCCA, right common carotid artery; RCIA, right common iliac artery; RECA, right external carotid artery; REXI, right external iliac artery; RFA, right femoral artery; RICA, right internal carotid artery; RRA, right renal artery; RSCA, right subclavian artery; RVA, right vertebral artery; SMA, superior mesenteric artery.

Similar articles

Cited by

References

    1. Numano F, Kakatu T.. Takayasu arteritis—five doctors in the history of Takayasu arteritis. Int J Cardiol 1996;54:S1–10. - PubMed
    1. Numano F. The story of Takayasu arteritis. Rheumatology 2002;41:103–6. - PubMed
    1. Kerr GS, Hallahan CW, Giordano J. et al. Takayasu arteritis. Ann Intern Med 1994;120:919–29. - PubMed
    1. Valsakumar AK, Valappil UC, Jorapur V. et al. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu’s arteritis. J Rheumatol 2003;30:1793–8. - PubMed
    1. Yang L, Zhang H, Jiang X. et al. Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol 2014;41:2439–46. - PubMed